Macrophage CD40 plays a minor role in obesity-induced metabolic dysfunction.

Obesity is a low-grade inflammatory disease that increases the risk for metabolic disorders. CD40-CD40L signaling plays a central role in obesity-induced inflammation. Genetic deficiency of CD40L in diet-induced obesity (DIO) ameliorates adipose tissue inflammation, hepatic steatosis and increases i...

Full description

Bibliographic Details
Main Authors: Suzanne A B M Aarts, Myrthe E Reiche, Myrthe den Toom, Linda Beckers, Marion J J Gijbels, Norbert Gerdes, Menno P J de Winther, Esther Lutgens
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6086432?pdf=render
_version_ 1818550166204973056
author Suzanne A B M Aarts
Myrthe E Reiche
Myrthe den Toom
Linda Beckers
Marion J J Gijbels
Norbert Gerdes
Menno P J de Winther
Esther Lutgens
author_facet Suzanne A B M Aarts
Myrthe E Reiche
Myrthe den Toom
Linda Beckers
Marion J J Gijbels
Norbert Gerdes
Menno P J de Winther
Esther Lutgens
author_sort Suzanne A B M Aarts
collection DOAJ
description Obesity is a low-grade inflammatory disease that increases the risk for metabolic disorders. CD40-CD40L signaling plays a central role in obesity-induced inflammation. Genetic deficiency of CD40L in diet-induced obesity (DIO) ameliorates adipose tissue inflammation, hepatic steatosis and increases insulin sensitivity. Unexpectedly, absence of CD40 worsened insulin resistance and caused excessive adipose tissue inflammation and hepatosteatosis. To investigate whether deficiency of macrophage CD40 is responsible for the phenotype observed in the CD40-/- mice, we generated CD40flflLysMcre and fed them a standard (SFD) and 54% high fat obesogenic diet (HFD) for 13 weeks. No differences in body weight, adipose tissue weight, adipocyte size, plasma cholesterol or triglyceride levels could be observed between CD40flflLysMcre and wild type (WT) mice. CD40flflLysMcre displayed no changes in glucose tolerance or insulin resistance, but had higher plasma adiponectin levels when fed a SFD. Liver weights, liver cholesterol and triglyceride levels, as well as the degree of hepatosteatosis were not affected by absence of macrophage CD40. CD40flflLysMcre mice displayed a minor increase in adipose tissue leukocyte infiltration on SFD and HFD, which did not result in differences in adipose tissue cytokine levels. We here show that loss of macrophage CD40 signaling does not affect obesity induced metabolic dysregulation and indicates that CD40-deficiency on other cell-types than the macrophage is responsible for the metabolic dysregulation, adipose tissue inflammation and hepatosteatosis that are observed in CD40-/- mice.
first_indexed 2024-12-12T08:42:49Z
format Article
id doaj.art-d814a689b6b64c32bf5208ea8e8a55b6
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T08:42:49Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d814a689b6b64c32bf5208ea8e8a55b62022-12-22T00:30:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01138e020215010.1371/journal.pone.0202150Macrophage CD40 plays a minor role in obesity-induced metabolic dysfunction.Suzanne A B M AartsMyrthe E ReicheMyrthe den ToomLinda BeckersMarion J J GijbelsNorbert GerdesMenno P J de WintherEsther LutgensObesity is a low-grade inflammatory disease that increases the risk for metabolic disorders. CD40-CD40L signaling plays a central role in obesity-induced inflammation. Genetic deficiency of CD40L in diet-induced obesity (DIO) ameliorates adipose tissue inflammation, hepatic steatosis and increases insulin sensitivity. Unexpectedly, absence of CD40 worsened insulin resistance and caused excessive adipose tissue inflammation and hepatosteatosis. To investigate whether deficiency of macrophage CD40 is responsible for the phenotype observed in the CD40-/- mice, we generated CD40flflLysMcre and fed them a standard (SFD) and 54% high fat obesogenic diet (HFD) for 13 weeks. No differences in body weight, adipose tissue weight, adipocyte size, plasma cholesterol or triglyceride levels could be observed between CD40flflLysMcre and wild type (WT) mice. CD40flflLysMcre displayed no changes in glucose tolerance or insulin resistance, but had higher plasma adiponectin levels when fed a SFD. Liver weights, liver cholesterol and triglyceride levels, as well as the degree of hepatosteatosis were not affected by absence of macrophage CD40. CD40flflLysMcre mice displayed a minor increase in adipose tissue leukocyte infiltration on SFD and HFD, which did not result in differences in adipose tissue cytokine levels. We here show that loss of macrophage CD40 signaling does not affect obesity induced metabolic dysregulation and indicates that CD40-deficiency on other cell-types than the macrophage is responsible for the metabolic dysregulation, adipose tissue inflammation and hepatosteatosis that are observed in CD40-/- mice.http://europepmc.org/articles/PMC6086432?pdf=render
spellingShingle Suzanne A B M Aarts
Myrthe E Reiche
Myrthe den Toom
Linda Beckers
Marion J J Gijbels
Norbert Gerdes
Menno P J de Winther
Esther Lutgens
Macrophage CD40 plays a minor role in obesity-induced metabolic dysfunction.
PLoS ONE
title Macrophage CD40 plays a minor role in obesity-induced metabolic dysfunction.
title_full Macrophage CD40 plays a minor role in obesity-induced metabolic dysfunction.
title_fullStr Macrophage CD40 plays a minor role in obesity-induced metabolic dysfunction.
title_full_unstemmed Macrophage CD40 plays a minor role in obesity-induced metabolic dysfunction.
title_short Macrophage CD40 plays a minor role in obesity-induced metabolic dysfunction.
title_sort macrophage cd40 plays a minor role in obesity induced metabolic dysfunction
url http://europepmc.org/articles/PMC6086432?pdf=render
work_keys_str_mv AT suzanneabmaarts macrophagecd40playsaminorroleinobesityinducedmetabolicdysfunction
AT myrtheereiche macrophagecd40playsaminorroleinobesityinducedmetabolicdysfunction
AT myrthedentoom macrophagecd40playsaminorroleinobesityinducedmetabolicdysfunction
AT lindabeckers macrophagecd40playsaminorroleinobesityinducedmetabolicdysfunction
AT marionjjgijbels macrophagecd40playsaminorroleinobesityinducedmetabolicdysfunction
AT norbertgerdes macrophagecd40playsaminorroleinobesityinducedmetabolicdysfunction
AT mennopjdewinther macrophagecd40playsaminorroleinobesityinducedmetabolicdysfunction
AT estherlutgens macrophagecd40playsaminorroleinobesityinducedmetabolicdysfunction